Answer
A risk to breastfed newborns or infants cannot be excluded with Ryaltris, so a decision must be made whether to stop breastfeeding or discontinue or abstain from Ryaltris, weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Ryaltris 25 micrograms/actuation+600 micrograms/actuation Nasal Spray, suspensionGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked